Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
Cytokine|May 4, 2021
Differential levels of IFNα subtypes in autoimmunity and viral infectionVincent Bondet, Mathieu P Rodero, Céline Posseme, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2021
Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib (GDC-0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled TrialDavid Isenberg, Richard Furie, Nicholas S Jones, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosisStephanie Guillet, Tomi Lazarov, Natasha Jordan, et al.
Lupus Science & Medicine|September 23, 2025
Towards a minimal core dataset for systemic lupus erythematosus studiesStephen McDonald, Jialin Teng, Chengde Yang, et al.
Annals of the Rheumatic Diseases|May 8, 2012
Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndromeJulia L Newton, James Frith, Danielle Powell, et al.
Annals of the Rheumatic Diseases|June 14, 2013
Health-related utility values of patients with primary Sjögren's syndrome and its predictorsDennis Lendrem, Sheryl Mitchell, Peter McMeekin, et al.
Swiss Medical Weekly|February 15, 2018
Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome RegistryAlexandre Dumusc, Wan-Fai Ng, Katherine James, et al.
Rheumatology (Oxford, England)|September 22, 2014
Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?Dennis Lendrem, Sheryl Mitchell, Peter McMeekin, et al.
Research and Practice in Thrombosis and Haemostasis|August 14, 2024
Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trialPrabal Mittal, Rafael Gafoor, Zara Sayar, et al.
Arthritis Care & Research|January 29, 2014
25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohortApinya Lertratanakul, Peggy Wu, Alan Dyer, et al.
Pageof 19